Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Up 4,000.0% in March

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 8,200 shares, a growth of 4,000.0% from the March 15th total of 200 shares. Based on an average daily volume of 20,900 shares, the days-to-cover ratio is presently 0.4 days.

Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF

Several institutional investors have recently bought and sold shares of the business. Bank of America Corp DE lifted its position in Invesco Nasdaq Biotechnology ETF by 2.9% during the first quarter. Bank of America Corp DE now owns 18,451 shares of the company’s stock valued at $382,000 after purchasing an additional 520 shares during the last quarter. UBS Group AG lifted its position in Invesco Nasdaq Biotechnology ETF by 259.3% during the first quarter. UBS Group AG now owns 1,254 shares of the company’s stock valued at $26,000 after purchasing an additional 905 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in Invesco Nasdaq Biotechnology ETF by 2.4% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 211,596 shares of the company’s stock valued at $4,194,000 after purchasing an additional 5,000 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Invesco Nasdaq Biotechnology ETF by 66.1% in the second quarter. Tower Research Capital LLC TRC now owns 27,946 shares of the company’s stock valued at $571,000 after acquiring an additional 11,122 shares during the period. Finally, Royal Bank of Canada purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF in the first quarter valued at $1,940,000.

Invesco Nasdaq Biotechnology ETF Stock Down 1.4 %

IBBQ stock opened at $21.34 on Thursday. Invesco Nasdaq Biotechnology ETF has a 52 week low of $18.18 and a 52 week high of $23.02. The company has a fifty day simple moving average of $22.05 and a two-hundred day simple moving average of $20.92. The firm has a market capitalization of $31.16 million, a P/E ratio of 16.48 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Tuesday, March 19th were given a dividend of $0.0435 per share. The ex-dividend date was Monday, March 18th. This represents a $0.17 annualized dividend and a yield of 0.82%.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.